First-line pembrolizumab in advanced non-small cell lung cancer patients with poor performance status.
Eur J Cancer
; 130: 155-167, 2020 05.
Article
in En
| MEDLINE
| ID: mdl-32220780
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Carcinoma, Non-Small-Cell Lung
/
Antibodies, Monoclonal, Humanized
/
Programmed Cell Death 1 Receptor
/
Lung Neoplasms
Type of study:
Observational_studies
/
Prognostic_studies
Limits:
Aged
/
Female
/
Humans
/
Male
Language:
En
Journal:
Eur J Cancer
Year:
2020
Document type:
Article
Country of publication:
United kingdom